Accepted for Publication: April 6, 2022.
Published Online: June 8, 2022. doi:10.1001/jamadermatol.2022.1756
Corresponding Author: Isabelle Hoorens, MD, PhD, Department of Dermatology, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent, Belgium (isabelle.hoorens@uzgent.be).
Author Contributions: Drs Hilhorst had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. These authors equally contributed to the work Dr Niels and Ms Deprez.
Concept and design: Hilhorst, Deprez, Grine, Lambert, Hoorens.
Acquisition, analysis, or interpretation of data: Hilhorst, Deprez, Pauwels, Hoorens.
Drafting of the manuscript: Hilhorst, Deprez, Lambert, Hoorens.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Hilhorst, Deprez, Hoorens.
Obtained funding: Hilhorst, Deprez, Lambert.
Administrative, technical, or material support: Hilhorst, Deprez.
Supervision: Grine, Lambert, Hoorens.
Conflict of Interest Disclosures: Dr Hilhorst reported research activities funding from Novartis by a Novartis Research Collaboration Agreement during the conduct of the study. Dr Deprez reported grants from Janssen-Cilag NV during the conduct of the study. Dr Grine reported speaker’s fees from AbbVie , Webinar fees from R-Biopharm , and speaker’s fees from Union Chimique Belge outside the submitted work. Dr Hoorens reported grants from Research Foundation Flanders (FWO) 12Y2420N during the conduct of the study. No other disclosures were reported.
Funding/Support: Novartis Research Collaboration Agreement, Value In Psoriasis chair Janssen-Cilag and Scientific Research Foundation-Flanders (FWO junior postdoctoral mandate: 12Y2420N). Reviewers were contracted by the Ghent University (UGent) and Ghent University Hospital (UZ Gent). The research activities of Dr Hilhorst and Ms Deprez are funded by a Novartis Research Collaboration Agreement and a chair Value In Psoriasis from Janssen-Cilag, respectively. The research activities of Dr Hoorens are supported by the Scientific Research Foundation-Flanders (FWO junior postdoctoral mandate: 12Y2420N).
Role of the Funder/Sponsor: The funding agencies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. They therefore accept no responsibility for the contents.
Additional Contributions: We thank all authors who provided us with additional data, thereby aiding us in obtaining a complete overview of the literature.
1.Marzorati
C , Pravettoni
G . Value as the key concept in the health care system: how it has influenced medical practice and clinical decision-making processes.
J Multidiscip Healthc. 2017;10:101-106. doi:
10.2147/JMDH.S122383PubMedGoogle ScholarCrossref 13.Maul
JT , Navarini
AA , Sommer
R ,
et al. Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice.
J Eur Acad Dermatol Venereol. 2019;33(4):700-708. doi:
10.1111/jdv.15324PubMedGoogle ScholarCrossref 14.Rasmussen
MK , Enger
M , Dahlborn
AK ,
et al. The importance of achieving clear or almost clear skin for patients: Results from the nordic countries of the global “clear about psoriasis” patient survey.
Acta Derm Venereol. 2019;99(2):158-163. doi:
10.2340/00015555-3048PubMedGoogle ScholarCrossref 15.Barbieri
JS , Miller
JJ , Nguyen
HP , Forman
HP , Bolognia
JL , VanBeek
MJ ; Group for Research of Policy Dynamics in Dermatology. Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children’s Health Insurance Program Reauthorization Act and the Merit-based Incentive Payment System.
J Am Acad Dermatol. 2017;76(6):1206-1212. doi:
10.1016/j.jaad.2017.01.032PubMedGoogle ScholarCrossref 20.Callis Duffin
K , Gottlieb
AB , Merola
JF , Latella
J , Garg
A , Armstrong
AW . Defining Outcome Measures for Psoriasis: The IDEOM Report from the GRAPPA 2016 Annual Meeting.
J Rheumatol. 2017;44(5):701-702. doi:
10.3899/jrheum.170151PubMedGoogle ScholarCrossref